You are here Home Resources Handbook tables Handbook tables Table. Recommendations for MenB vaccine for people with a specified medical condition that increases their risk of invasive meningococcal disease Listen Print Share Twitter Facebook Email Age at start of vaccine course Dose requirements for people with a specified medical condition associated with increased risk of meningococcal disease 6 weeks to 5 months 4 doses (8 weeks between doses; 4th dose at 12 months of age or 8 weeks after 3rd dose, whichever is later) 6–11 months 3 doses (8 weeks between 1st and 2nd doses; 3rd dose at 12 months of age or 8 weeks after 2nd dose, whichever is later) ≥12 months 2 doses (8 weeks between doses) Booster doses for all ages For people with ongoing increased risk of invasive meningococcal disease who completed the primary series at: ≤6 years of age — single booster dose 3 years after completing the primary schedule ≥7 years of age — single booster dose 5 years after completing the primary schedule Page history Last updated 11 December 2024 Last reviewed 11 December 2024 Related diseases Meningococcal disease Is there anything wrong with this page?
